Circulating Biomarkers for Laboratory Diagnostics of Atherosclerosis-Literature Review

Gabriela Bordeianu1, Ivona Mitu1, Raluca Stefania Stanescu1

  • 1Department of Morpho-Functional Sciences II, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.

Insights

This study reviews biomarkers for atherosclerosis, a cardiovascular disease. It highlights the link between lipid profiles, inflammation, and early vascular lesion detection for better patient management.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Molecular Pathophysiology

Background:

  • Atherosclerosis poses a significant long-term burden on the cardiovascular system.
  • Effective management relies on traditional and emerging biomarkers to assess disease progression.
  • Detecting incipient vascular lesions requires advanced predictive marker models.

Purpose of the Study:

  • To analyze recent literature on molecular mechanisms of biomarkers in atherosclerosis.
  • To understand the role of biomarkers in the atherosclerotic cascade.
  • To explore the linkage between lipid profiles, inflammation, and disease evolution.

Main Methods:

  • Literature review of recent data.
  • Analysis of molecular mechanisms of biomarkers.
  • Investigation of biomarker involvement in atherosclerotic pathophysiology.

Main Results:

  • Advances have strengthened the understanding of the lipid profile-inflammation link.
  • Biomarkers are crucial for evaluating atherosclerotic stages and early lesions.
  • The study synthesizes current knowledge on molecular pathways.

Conclusions:

  • Biomarker research is vital for understanding and managing atherosclerosis.
  • Improved predictive models are needed for early vascular lesion detection.
  • A comprehensive view of lipid-inflammation interplay aids therapeutic strategies.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
138
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
229
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46